News items related to: News
-
Breakthrough success as reformed patent law enters into force in Ukraine
Ukraine’s reformed patent law provides a framework to prevent unlawful patents and monopolies on essential drugs, which have restricted access...
-
Report: 10 years of community-monitoring of ARV procurement in Russia
ITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
-
USA-Kenya Trade Agreement: No IP barriers to affordable medicines
“Access to medicines is a fundamental element of the right to health” states our partner, the Kenya Legal and Ethical...
-
CPTPP: Global civil society writes to Thai Prime Minister warning access to treatment is at risk
Civil society groups and non-government organizations in Thailand have, since March 2020, been expressing their grave concerns over the adverse...
-
CSO Open Letter to Thailand’s Prime Minister
CSO Open Letter to Thailand’s Prime Minister and the Chairperson of the Special Committee on the Study of the CPTPP’s...
-
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Positive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
-
Thai civil society opposes patent on an influenza drug, now used for COVID-19
Favipiravir, originally approved as an influenza drug, is being used to treat COVID-19 patients with pneumonia, alongside anti-malarial and anti-retroviral...
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
This week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
Humanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
New data: Treat HIV for just four weeks of global pharmaceutical sales
The Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at...
-
AIDS 2020 leadership workshop: Strategies for lowering drug prices
Activists, policy-makers, researchers and healthcare providers joined a leadership workshop led by ITPC’s Make Medicines Affordable campaign at AIDS 2020...